Growing community of inventors

Arlington, MA, United States of America

Douglas F Burdi

Average Co-Inventor Count = 6.45

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 10

Douglas F BurdiShomir Ghosh (3 patents)Douglas F BurdiTracy J Jenkins (3 patents)Douglas F BurdiGang Li (3 patents)Douglas F BurdiBing Guan (3 patents)Douglas F BurdiMingshi Dai (3 patents)Douglas F BurdiCharles A Minor (3 patents)Douglas F BurdiRobert A Bennett (3 patents)Douglas F BurdiMichele L R Heffernan (2 patents)Douglas F BurdiLinghong Xie (2 patents)Douglas F BurdiCarrie A Bowen (2 patents)Douglas F BurdiLee W Herman (2 patents)Douglas F BurdiLee W Herman (1 patent)Douglas F BurdiLinghong Xie (1 patent)Douglas F BurdiMichele L R Heffernan (1 patent)Douglas F BurdiDouglas F Burdi (5 patents)Shomir GhoshShomir Ghosh (70 patents)Tracy J JenkinsTracy J Jenkins (19 patents)Gang LiGang Li (19 patents)Bing GuanBing Guan (17 patents)Mingshi DaiMingshi Dai (6 patents)Charles A MinorCharles A Minor (4 patents)Robert A BennettRobert A Bennett (3 patents)Michele L R HeffernanMichele L R Heffernan (23 patents)Linghong XieLinghong Xie (13 patents)Carrie A BowenCarrie A Bowen (5 patents)Lee W HermanLee W Herman (3 patents)Lee W HermanLee W Herman (1 patent)Linghong XieLinghong Xie (1 patent)Michele L R HeffernanMichele L R Heffernan (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Millennium Pharmaceuticals Limited (3 from 850 patents)

2. Sunovion Pharmaceuticals Inc. (2 from 130 patents)

3. Pgi Drug Discovery LLC (2 from 16 patents)


5 patents:

1. 11491133 - Heteroaryl-isochroman compounds and uses thereof

2. 10780074 - Compounds and uses thereof

3. 8063222 - Aryl sulfonamides useful as inhibitors of chemokine receptor activity

4. 7491827 - Aryl sulfonamides useful as inhibitors of chemokine receptor activity

5. 7378525 - CCR8 inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…